Evaluation of health utility in trial-based cost–utility analyses for major cardiovascular disease: protocol for a systematic review
Introduction The global incidence of cardiovascular disease (CVD) is high, and the medical costs associated with its management have been increasing. Cost–utility analyses (CUAs) are essential for understanding the value of healthcare interventions and for decision-making. A majority of the CUAs for...
Main Authors: | Makoto Saito, Yan Luo, Osamu Yamaguchi, Kazumichi Yamamoto, Hiroshi Kawakami, Yasuhisa Nakao, Shigehiro Miyazaki |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-05-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/13/5/e067045.full |
Similar Items
-
Data on Utility in Cost–Utility Analyses of Genetic Screen-and-Treat Strategies for Breast and Ovarian Cancer
by: Julia Simões Corrêa Galendi, et al.
Published: (2021-09-01) -
2212 A systematic overview of cost-utility analyses in dermatology
by: David G. Li, et al.
Published: (2018-06-01) -
Utility of constraints reflecting system stability on analyses for biological models.
by: Yoshiaki Kariya, et al.
Published: (2022-09-01) -
Energy utilization in major crop cultivation
by: Elsoragaby, Suha, et al.
Published: (2019) -
Cost Utility of Bronchial Thermoplasty for Severe Asthma: Implications for Future Cost-Effectiveness Analyses Based on Phenotypic Heterogeneity
by: Keim-Malpass J, et al.
Published: (2022-06-01)